c-Met-IN-12 structure
|
Common Name | c-Met-IN-12 | ||
|---|---|---|---|---|
| CAS Number | 2426675-70-7 | Molecular Weight | 576.62 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C34H29FN4O4 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of c-Met-IN-12c-Met-IN-12 (compound 4r) is an orally active, potent and selective type II c-Met kinase inhibitor, with an IC50 of 10.6 nM. c-Met-IN-12 displays high inhibitory effects (inhibition rate > 80% in 1 μM) against AXL, Mer and TYRO3 kinases. c-Met-IN-12 can be used a scaffold for further kinase selectivity enhancement. c-Met-IN-12 shows antitumor efficacy[1]. |
| Name | c-Met-IN-12 |
|---|
| Description | c-Met-IN-12 (compound 4r) is an orally active, potent and selective type II c-Met kinase inhibitor, with an IC50 of 10.6 nM. c-Met-IN-12 displays high inhibitory effects (inhibition rate > 80% in 1 μM) against AXL, Mer and TYRO3 kinases. c-Met-IN-12 can be used a scaffold for further kinase selectivity enhancement. c-Met-IN-12 shows antitumor efficacy[1]. |
|---|---|
| Related Catalog | |
| Target |
c-Met:10.6 nM (IC50) |
| In Vivo | c-Met-IN-12 (compound 4r) (Tumor-bearing nude mice, 45 mg/kg, Orally, Q.D. for 21 days) exhibits significant tumor growth inhibition (93%) in a U-87MG human gliobastoma xenograft model[1]. |
| References |
| Molecular Formula | C34H29FN4O4 |
|---|---|
| Molecular Weight | 576.62 |